Oxybutynin hydrochloride
-
Oxybutynin hydrochloride
structure -
-
CAS No:
1508-65-2
-
Formula:
C22H31NO3.ClH
-
Chemical Name:
Oxybutynin hydrochloride
-
Synonyms:
Benzeneacetic acid,α-cyclohexyl-α-hydroxy-,4-(diethylamino)-2-butyn-1-yl ester,hydrochloride (1:1);Cyclohexaneglycolic acid,α-phenyl-,4-(diethylamino)-2-butynyl ester,hydrochloride;Benzeneacetic acid,α-cyclohexyl-α-hydroxy-,4-(diethylamino)-2-butynyl ester,hydrochloride;2-Butyn-1-ol,4-(diethylamino)-,α-phenylcyclohexaneglycolate (ester),hydrochloride;MJ 4309-1;4-(Diethylamino)-2-butynyl α-phenylcyclohexaneglycolate hydrochloride;Oxybutynin hydrochloride;Oxybutynin chloride;MJ 50-58;Tropax;Cystrin;Dridase;Pollakisu;Gelnique;Neoxy Tape;99937-06-1
- Categories:
-
CAS No:
Description
Oxybutynin is an anticholinergic medication used to relieve urinary and bladder difficulties.Target: mAChROxybutynin is an anticholinergic medication used to relieve urinary and bladder difficulties, including frequent urination and inability to control urination (urge incontinence), by decreasing muscle spasms of the bladder. Oxybutynin competitively antagonizes the M1, M2, and M3 subtypes of the muscarinic acetylcholine receptor. It also has direct spasmolytic effects on bladder smooth
Oxybutynin hydrochloride Basic Attributes
393.95
393.207062
216-139-7
759108
DTXSID3045356
2922509090
Characteristics
49.8
4.14490
white
129.5 °C
494.4ºC at 760 mmHg
H2O: soluble 50mg/mL
room temp
1.37E-10mmHg at 25°C
186.1 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]
Safety Information
NONH for all modes of transport
22
36
GV2800000
Xn
P301 + P312 + P330
H302
|Warning|H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]|P261, P264, P270, P271, P272, P273, P280, P301+P312, P302+P352, P304+P340, P305+P351+P338, P312, P321, P330, P333+P313, P337+P313, P363, P391, P403+P233, P405, and P501|Aggregated GHS information provided by 53 companies from 7 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Drug Information
Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system. (See all compounds classified as Muscarinic Antagonists.)|Drugs used in the treatment of urogenital conditions and diseases such as URINARY INCONTINENCE; PROSTATIC HYPERPLASIA; and ERECTILE DYSFUNCTION. (See all compounds classified as Urological Agents.)|Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)
4-(diethylamino)-2-butynyl-alpha-cyclohexyl-alpha-hydroxybenzeneacetate
Oxybutynin hydrochloride Use and Manufacturing
An antagonist of M1, M2, & M3 muscarinic acetylcholine receptors Antispasmodic, used to treat urinary urgency, frequent urination, urinary incontinence, nocturia and enuresis
Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients
Computed Properties
Molecular Weight:393.9
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:4
Rotatable Bond Count:8
Exact Mass:393.2070716
Monoisotopic Mass:393.2070716
Topological Polar Surface Area:49.8
Heavy Atom Count:27
Complexity:490
Undefined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes
Drug Function and Efficacy
It has a direct spasmolytic effect on smooth muscle and can inhibit the muscarinic effect of acetylcholine on smooth muscle. It can selectively act on the detrusor muscle of the bladder, reduce the intra-bladder pressure, increase the bladder capacity, reduce involuntary bladder contractions and relieve urinary urgency, urinary frequency and urinary incontinence. It has no blocking effect on skeletal muscle ganglia and autonomic ganglia.
Registered Holders
-
THINQ PHARMA-CRO LTD
Active
United States
-
APITORIA PHARMA PRIVATE LTD
Active
United States
-
Pcas
Active
Japan
Recommended Suppliers of Oxybutynin hydrochloride
-
CN
5 YRS
Business licensed Certified factoryManufactory Supplier of D-Biotin,Tobramycin base,L(-)-Carnitine base,Polymyxin B sulfate USP,Kanamycin sulfate monohydrate,Finasteride 99% USP -
CN
5 YRS
Business licensedTrader Supplier of Intermediates,Building blocks,API,Silicones,Peptides,Lab chemicals,Biochemicals,Pharmaceuticals,Screening Compounds,Food Additives
Learn More Other Chemicals
-
4H-1-Benzopyran-4-one, 2-[4-[3-(dibutylamino)propoxy]-3,5-dimethylbenzoyl]-, hydrochloride (1:1)
67652-33-9
-
Cyclopropanecarboxylic acid, 1-amino-2-ethenyl-, ethyl ester, hydrochloride (9CI)
681807-60-3
-
CYCLOPENTYL-(3,4,5-TRIMETHOXY-BENZYL)-AMINE HYDROCHLORIDE
1052525-88-8
-
2-Cyclopropylbenzenemethanamine hydrochloride Formula
118184-64-8
-
Des[4-(2-cycloproylMethoxy)] Betaxolol Hydrochloride Formula
464877-45-0
-
Ethanamine, 2-(decylthio)-, hydrochloride (1:1) Formula
36362-09-1
-
4,7-Dichloro-2-propylquinoline hydrochloride Structure
1204812-22-5
-
6,7-Dichloro-4-hydrazino-2-methylquinoline hydrochloride Structure
1170377-12-4
-
What is 2,8-Diazaspiro[4.5]decan-1-one, 2-[(4-bromophenyl)methyl]-, hydrochloride (1:1)
832710-56-2
-
What is 6,7-Dichloro-4-hydrazinoquinoline hydrochloride
1171843-02-9